| Breaking the Integrin Hinge: A DEFINED STRUCTURAL CONSTRAINT REGULATES INTEGRIN SIGNALING (∗) PE Hughes, F Diaz-Gonzalez, L Leong, C Wu, JA McDonald, SJ Shattil, ... Journal of Biological Chemistry 271 (12), 6571-6574, 1996 | 758 | 1996 |
| Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation … JM Álvaro-Gracia, JA Jover, R García-Vicuña, L Carreño, A Alonso, ... Annals of the rheumatic diseases 76 (1), 196-202, 2017 | 243 | 2017 |
| Trans-dominant inhibition of integrin function. F Diaz-Gonzalez, J Forsyth, B Steiner, MH Ginsberg Molecular biology of the cell 7 (12), 1939-1951, 1996 | 232 | 1996 |
| A phase III, randomized, controlled trial of apremilast in patients with psoriatic arthritis: results of the PALACE 2 trial M Cutolo, GE Myerson, RM Fleischmann, F Lioté, F Díaz-González, ... The Journal of Rheumatology 43 (9), 1724-1734, 2016 | 213 | 2016 |
| Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs. F Diaz-Gonzalez, I Gonzalez-Alvaro, MR Campanero, F Mollinedo, ... The Journal of clinical investigation 95 (4), 1756-1765, 1995 | 210 | 1995 |
| CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast‐like synoviocytes from rheumatoid arthritis patients R García‐Vicuña, MV Gómez‐Gaviro, MJ Domínguez‐Luis, MK Pec, ... Arthritis & Rheumatism 50 (12), 3866-3877, 2004 | 203 | 2004 |
| An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis CP Denton, M Engelhart, N Tvede, H Wilson, K Khan, X Shiwen, ... Annals of the rheumatic diseases 68 (9), 1433-1439, 2009 | 148 | 2009 |
| Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA … S Castañeda, MA Martín-Martínez, C González-Juanatey, J Llorca, ... Seminars in arthritis and rheumatism 44 (6), 618-626, 2015 | 147 | 2015 |
| Expression and regulation of the metalloproteinase ADAM-8 during human neutrophil pathophysiological activation and its catalytic activity on L-selectin shedding M Gómez-Gaviro, M Domínguez-Luis, J Canchado, J Calafat, H Janssen, ... The journal of immunology 178 (12), 8053-8063, 2007 | 145 | 2007 |
| Adhesion molecules in inflammatory diseases R González-Amaro, F Diaz-González, F Sánchez-Madrid Drugs 56 (6), 977-988, 1998 | 145 | 1998 |
| Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1). AA Postigo, R Garcia-Vicuna, F Diaz-Gonzalez, AG Arroyo, ... The Journal of clinical investigation 89 (5), 1445-1452, 1992 | 140 | 1992 |
| NSAIDs: learning new tricks from old drugs F Díaz‐González, F Sánchez‐Madrid European journal of immunology 45 (3), 679-686, 2015 | 139 | 2015 |
| Association between severity of periodontitis and clinical activity in rheumatoid arthritis patients: a case–control study B Rodríguez-Lozano, J González-Febles, JL Garnier-Rodríguez, ... Arthritis research & therapy 21, 1-12, 2019 | 138 | 2019 |
| Nontropical pyomyositis in adults JJ Gomez-Reino, JJ Aznar, JL Pablos, F Diaz-Gonzalez, A Laffon Seminars in Arthritis and Rheumatism 23 (6), 396-405, 1994 | 131 | 1994 |
| Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology D Seoane-Mato, C Sánchez-Piedra, L Silva-Fernández, F Sivera, ... Reumatología Clínica (English Edition) 15 (2), 90-96, 2019 | 127 | 2019 |
| Influence of disease activity on the physical activity of rheumatoid arthritis patients V Hernandez-Hernandez, I Ferraz-Amaro, F Díaz-González Rheumatology 53 (4), 722-731, 2014 | 117 | 2014 |
| Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice A Santana, C Medina, MC Paz-Cabrera, F Díaz-Gonzalez, E Farré, ... World journal of gastroenterology: WJG 12 (40), 6464, 2006 | 114 | 2006 |
| The CCR2 receptor as a therapeutic target M Feria, F Díaz-González Expert Opinion on Therapeutic Patents 16 (1), 49-57, 2006 | 105 | 2006 |
| Inhibition of leukocyte adhesion: an alternative mechanism of action for anti-inflammatory drugs F Dı́az-González, F Sánchez-Madrid Immunology today 19 (4), 169-172, 1998 | 105 | 1998 |
| Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: scientific evidence and expert opinion MA Martín-Martínez, C González-Juanatey, S Castañeda, J Llorca, ... Seminars in Arthritis and Rheumatism 44 (1), 1-8, 2014 | 86 | 2014 |
